News Wellcome Trust awards $8m cash injection to trial schizophre... The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials.
Views & Analysis Digital health round-up: Apple opens clinics for employees Richard Staines gives a round-up of the latest digital health news
News Novartis to develop digital therapies with Pear Deal covers digital therapies for MS and schizophrenia
News Boehringer latest to axe Alzheimer's drug Company will trial BI 409306 in schizophrenia instead.
News Boehringer collaborates with Autifony on schizophrenia drug Deal could be worth 627.5 million euros
News BMS settles US off-label marketing case for $19.5m BMS illegally promoted schizophrenia drug, says attorney general
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.